Iambic Therapeutics at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Iambic Therapeutics brings 2 presentations to ENA 2026 in Barcelona. Its posters centre on new small-molecule inhibitors in preclinical development. They present IAM-C1, a selective dual CDK2/CDK4 inhibitor with a favorable tolerability profile, and IAM-K2, a brain-penetrant KIF18A inhibitor aimed at cancers with chromosomal instability.
| Organization | ENA 2026 Attendance |
|---|---|
Iambic Therapeutics San Diego, California | |
Clinical-stage biotech using AI-driven drug discovery to develop small-molecule cancer therapies. | Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from Iambic Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction